Research Overview
Eloralintide (LY3841136) is a long-acting amylin analog designed to selectively activate the amylin 1 receptor (AMY1R). Research has focused on appetite regulation, energy intake, body-weight regulation, fat mass, and metabolic function.
Quality & Testing
Novanix Labs evaluates compounds for purity, mass, and identity as part of our quality-assurance process. Analytical testing is used to verify compound identity, assess chemical purity, and confirm the amount of material present. Testing documentation is maintained as part of our commitment to consistency, transparency, and research standards.
Additional Research Information
Eloralintide preferentially activates AMY1R while exhibiting substantially lower activity at the calcitonin receptor and AMY3R. Human clinical research has examined its effects on appetite and body weight, with Phase 1 research reporting dose-dependent reductions in body weight during once-weekly administration. Its selective amylin-receptor activity makes it an important compound for research into satiety signaling, energy balance, adiposity, and metabolic regulation.